Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-Myeloablative Allo-PBSC Transplant and DLI for Metastatic Melanoma
NCT00006233Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jan 2000
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of therapeutic allogeneic lymphocytes in melanoma, sponsored by Fred Hutchinson Cancer Center. Started Jan 2000; status: completed.
02
Drugs
therapeutic allogeneic lymphocytes
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00006233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006233.